Oxybutynin Chloride NDC 23155-913

NDC codes

FDA NDC Directory

Product NDC (as listed)23155-913Labeler and product segments. Claims need a package NDC.

Product NDC at billing width23155-0913Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package
23155-913-01	23155091301	100 TABLET in 1 BOTTLE, PLASTIC (23155-913-01)Marketed from Jun 1, 2026
23155-913-05	23155091305	500 TABLET in 1 BOTTLE, PLASTIC (23155-913-05)Marketed from Jun 1, 2026
23155-913-10	23155091310	1000 TABLET in 1 BOTTLE, PLASTIC (23155-913-10)Marketed from Jun 1, 2026

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Oxybutynin Chloride
Generic name (nonproprietary): oxybutynin chloride
Active ingredients: Oxybutynin chloride — 5 mg/1
Dosage form: Tablet
Route: Oral
Labeler: Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc.
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 211682
Marketing start: Jun 1, 2026
Listing expires: Dec 31, 2027
Other FDA classes: Cholinergic Muscarinic Antagonists (Mechanism)
Identifiers: Product ID 23155-913_7adfd07f-bfc6-4403-8f1e-fdc6650dbc50SPL ID 7adfd07f-bfc6-4403-8f1e-fdc6650dbc50SPL set ID 73d715dc-868d-4194-b668-4c39ababa698RxCUI 863664UNII L9F3D9RENQUPC 0323155913101, 0323155913019
Pharmacologic class: Cholinergic Muscarinic Antagonist

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N423155091301 followed by a unit qualifier and the quantity

Package 23155-0913-01. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective May 20, 2026.

Indications (excerpt from the label)

INDICATIONS AND USAGE Oxybutynin chloride tablets are indicated for the relief of symptoms of bladder instability associated with voiding in patients with uninhibited neurogenic or reflex neurogenic bladder (i.e., urgency, frequency, urinary leakage, urge incontinence, dysuria).

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)